 |
Previous Article | Next Article 
The Journal of Neuroscience, November 15, 1998, 18(22):9547-9555
Long-Lasting Induction of Astrocytic Basic Fibroblast Growth
Factor by Repeated Injections of Amphetamine: Blockade by Concurrent
Treatment with a Glutamate Antagonist
Cecilia
Flores,
Demetra
Rodaros, and
Jane
Stewart
Center for Studies in Behavioral Neurobiology, Department of
Psychology, Concordia University, Montreal, Quebec, Canada, H3G 1M8
Repeated administration of stimulant drugs leads to lasting changes
in their behavioral and neurochemical effects. These changes are
initiated by drug actions in the somatodendritic regions of midbrain
dopaminergic neurons in the ventral tegmental area (VTA) and substantia
nigra pars compacta (SNc) and continue to develop for a period of time
after termination of drug treatment. Here we show that repeated
administration of amphetamine (3.0 mg/kg, i.p.; three injections, once
every other day) results in sustained increases in basic fibroblast
growth factor immunoreactivity (bFGF-IR) in both VTA and SNc,
200-500% over that seen in saline-treated animals. Increases were
observed 24 hr, 72 hr, 1 week and 1 month after the last drug
injection. Because glutamate participates in the development of
sensitization to stimulant drugs, we assessed the effect of the
glutamate antagonist, kynurenic acid (KYN), on amphetamine-induced
bFGF-IR. Coadministration of KYN prevented the increases in bFGF-IR in
both VTA and SNc assessed 1 week after the amphetamine treatment. No
changes in bFGF-IR were observed in the nucleus accumbens or dorsal
striatum. bFGF-IR was found to be associated with astrocytes and not
with dopaminergic neurons. These findings suggest that sustained
enhancement of astrocytic bFGF expression in DA somatodendritic regions
is a mechanism whereby stimulant drugs exert enduring effects on
midbrain DA function. We hypothesize that increased glutamatergic
activity elicited by amphetamine and other stimulant drugs places
excessive demands on the functioning of DA neurons recruiting
regulatory and neuroprotective processes that lead to enduring changes
in DA neuron functioning and connectivity.
Key words:
bFGF; amphetamine; sensitization; glutamate; dopamine; neurotrophic factors
Copyright © 1998 Society for Neuroscience 0270-6474/98/18229547-09$05.00/0
This article has been cited by other articles:

|
 |

|
 |
 
C. M. Papadopoulos, S.-Y. Tsai, V. Guillen, J. Ortega, G. L. Kartje, and W. A. Wolf
Motor Recovery and Axonal Plasticity With Short-Term Amphetamine After Stroke
Stroke,
January 1, 2009;
40(1):
294 - 302.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Stewart
Psychological and neural mechanisms of relapse
Phil Trans R Soc B,
October 12, 2008;
363(1507):
3147 - 3158.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Kaga, W. J. Shoemaker, M. Furusho, M. Bryant, J. Rosenbluth, S. E. Pfeiffer, L. Oh, M. Rasband, C. Lappe-Siefke, K. Yu, et al.
Mice with Conditional Inactivation of Fibroblast Growth Factor Receptor-2 Signaling in Oligodendrocytes Have Normal Myelin But Display Dramatic Hyperactivity when Combined with Cnp1 Inactivation.
J. Neurosci.,
November 22, 2006;
26(47):
12339 - 12350.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Kolb, G. Gorny, Y. Li, A.-N. Samaha, and T. E. Robinson
Amphetamine or cocaine limits the ability of later experience to promote structural plasticity in the neocortex and nucleus accumbens
PNAS,
September 2, 2003;
100(18):
10523 - 10528.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. B. NICULESCU III, D. S. SEGAL, R. KUCZENSKI, T. BARRETT, R. L. HAUGER, and J. R. KELSOE
Identifying a series of candidate genes for mania and psychosis: a convergent functional genomics approach
Physiol Genomics,
November 9, 2000;
4(1):
83 - 91.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Flores, N. Salmaso, S. Cain, D. Rodaros, and J. Stewart
Ovariectomy of Adult Rats Leads to Increased Expression of Astrocytic Basic Fibroblast Growth Factor in the Ventral Tegmental Area and in Dopaminergic Projection Regions of the Entorhinal and Prefrontal Cortex
J. Neurosci.,
October 1, 1999;
19(19):
8665 - 8673.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Flores, A.-N. Samaha, and J. Stewart
Requirement of Endogenous Basic Fibroblast Growth Factor for Sensitization to Amphetamine
J. Neurosci.,
January 15, 2000;
20(2):
RC55 - RC55.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|

|